Clinical characteristics of type 2 diabetes patients with discordance between HbA1c and fasting plasma glucose in the real world: An analysis of the ORBIT study-Reference-Cited by-同舟云学术

Clinical characteristics of type 2 diabetes patients with discordance between HbA1c and fasting plasma glucose in the real world: An analysis of the ORBIT study

Published:2018-01-26 Issue:4 Volume:34 Page:e2977
ISSN:1520-7552
Container-title:Diabetes/Metabolism Research and Reviews
language:en
Short-container-title:Diabetes Metab Res Rev

Author:

Shu Hua¹²^ORCID,Lu Juming¹,Zhang Puhong³,Zhu Dongshan³,Li Xian³,Ji Jiachao³,Zhao Fang³,Ji Linong⁴^ORCID

Affiliation:

1. Department of Endocrinology; Chinese PLA General Hospital; Beijing China

2. Department of Endocrinology and Metabolism; Tianjin Medical University General Hospital; Tianjin China

3. The George Institute for Global Health at Peking University Health Science Center; Beijing China

4. Department of Endocrinology; Peking University People's Hospital; Beijing China

Funder

Sanofi-Aventis Korea Company

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference25 articles.

1. 5. Glycemic Targets;American Diabetes Association;Diabetes Care,2016

2. A1C versus glucose testing: a comparison;Sacks;Diabetes Care,2011

3. Association of A1C with cardiovascular disease and metabolic syndrome in Asian Indians with normal glucose tolerance;Dilley;Diabetes Care,2007

4. A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes;Rosenstock;Diabetologia,2008

5. Treat-to-target trials: uses, interpretation and review of concepts;Garber;Diabetes Obes Metab,2014

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. iGlarLixi reduces residual hyperglycemia in Japanese patients with type 2 diabetes uncontrolled on basal insulin: A post‐hoc analysis of the LixiLan JP‐L trial;Journal of Diabetes Investigation;2021-06-19

2. Postchallenge glucose increment was associated with hemoglobin glycation index in subjects with no history of diabetes;Journal of Investigative Medicine;2021-02-01